Patents by Inventor Lirio Milenka Arevalo-Soliz

Lirio Milenka Arevalo-Soliz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100189
    Abstract: MiniVectors and compositions containing MiniVectors that target genes implicated in IPF selected from CDH11, STAT3, STAT6, FoxM1, MDM2, TGF?, SMAD, PDGFA, or TLR4 and/or increase intracellular levels of reduced glutathione, relaxin, and p53, are provided, along with uses in the treatment of idiopathic pulmonary fibrosis.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 28, 2024
    Applicants: Twister Biotech, Inc, Baylor College of Medicine
    Inventors: E. Lynn ZECHIEDRICH, Lirio Milenka AREVALO-SOLIZ, Daniel James CATANESE, JR., Jonathan Marcus FOGG, Christopher E. COKER
  • Publication number: 20240093226
    Abstract: MiniVectors and compositions containing MiniVectors that are ultrapure, and methods of making and using ultrapure MiniVectors for gene therapy uses, including long term repeated gene therapy uses.
    Type: Application
    Filed: September 8, 2022
    Publication date: March 21, 2024
    Applicants: BAYLOR COLLEGE OF MEDICINE, BAYLOR COLLEGE OF MEDICINE
    Inventors: E. Lynn ZECHIEDRICH, Jonathan Marcus FOGG, Lirio Milenka AREVALO-SOLIZ, Daniel James CATANESE, Christopher E. COKER
  • Publication number: 20230190955
    Abstract: Compositions containing MiniVectors and gene therapy uses, including long term repeated gene therapy uses, to treat liver fibrosis or liver cancer.
    Type: Application
    Filed: October 20, 2022
    Publication date: June 22, 2023
    Applicants: BAYLOR COLLEGE OF MEDICINE, TWISTER BIOTECH, INC.
    Inventors: E. LYNN ZECHIEDRICH, LIRIO MILENKA AREVALO-SOLIZ, Daniel James CATANESE, JR., Jonathan Marcus FOGG, Christopher E. COKER, SANDEEP AGARWAL
  • Publication number: 20200048716
    Abstract: MiniVectors and compositions containing MiniVectors that target ovarian cancer genes selected from FOXM1, AKT, CENPA, PLK1, CDC20, BIRC5, AURKB, CCNB1, CDKN3, BCAM-AKT2, CDKN2D-WDFY2, SLC25A6, CIP2A, CD133, ALDH1A1, CD44, SALL4, and/or PRDM16, alone or in any combination, are provided, along with uses in the treatment of ovarian cancer.
    Type: Application
    Filed: November 5, 2018
    Publication date: February 13, 2020
    Inventors: E. Lynn Zechiedrich, Martin M. Matzuk, Laising Yen, Zhifeng Yu, Lirio Milenka Arevalo-Soliz, Daniel James Catanese, JR., Jonathan Marcus Fogg, Christopher Elbert Coker